Model
Edge
Revance Therapeutics Inc.
0001803375
Filing Type
4
Filing Date
2/5/2025
Updated
2/6/25, 1:58 PM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership